Feb 24, 2026 04:18PM
Feb 10, 2026 08:31AM
Feb 5, 2026 08:04AM
Jan 22, 2026 08:13AM
Jan 21, 2026 08:13AM
Jan 15, 2026 08:17AM
Jan 2, 2026 08:14AM Hoth Therapeutics files two patents for cancer skin toxicity treatments
Nov 20, 2025 08:13AM
Nov 17, 2025 06:03AM
Oct 27, 2025 07:49AM
Oct 21, 2025 08:23AM
Oct 8, 2025 08:03AM
Sep 24, 2025 08:14AM
Sep 16, 2025 08:16AM Hoth Therapeutics submits European trial application, adds crypto to treasury
Sep 10, 2025 08:29AM
Sep 4, 2025 08:20AM
Sep 2, 2025 08:16AM
Jul 29, 2025 07:58AM
Jul 22, 2025 08:19AM
Jun 25, 2025 08:38AM
Jun 25, 2025 08:29AM Hoth Therapeutics Inc. (HOTH) and Silo Pharma (SILO) form a 50/50 JV to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs
Jun 24, 2025 10:36AM
Jun 18, 2025 01:35PM
Jun 18, 2025 08:22AM
Jun 12, 2025 09:17AM
Jun 11, 2025 08:28AM
Jun 5, 2025 08:13AM
May 12, 2025 07:31AM Hoth Therapeutics Inc. (HOTH) Reports Positive Preclinical Results for HT-KIT
Apr 17, 2025 08:02AM
Apr 15, 2025 08:19AM
Apr 2, 2025 07:58AM
Mar 31, 2025 04:45PM
Mar 26, 2025 08:02AM
Mar 18, 2025 08:07AM
Mar 10, 2025 08:03AM Hoth Therapeutics Inc. (HOTH) to Submit Expanded Access Application for HT-001
Mar 5, 2025 01:40PM
Mar 4, 2025 08:16AM
Feb 10, 2025 08:22AM
Jan 21, 2025 08:30AM
Jan 8, 2025 01:28PM
Jan 7, 2025 08:29AM
Dec 26, 2024 07:59AM Hoth Therapeutics (HOTH) Enters Partnership with the Department of Veterans Affairs to Develop Obesity Treatment
Nov 20, 2024 07:39AM
Nov 4, 2024 06:49AM
Oct 29, 2024 12:44PM
Oct 16, 2024 06:57AM
Oct 15, 2024 06:40AM
Oct 11, 2024 06:50AM
Sep 5, 2024 08:06AM Hoth Therapeutics (HOTH) Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001
Aug 21, 2024 08:19AM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All